TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clinical remission at week 56
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Driver acceptance of alerts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Initiation of adjuvant AI treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Switch to AI after tamoxifen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuation of AI after tamoxifen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time until cervical ripening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean time until vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Percentage of vaginal deliveries within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Use of oral steroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General practice consultations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: risk of persistent MMD
Endpoint domain: Mortality/survival
Primary endpoint: incident MMD
Endpoint domain: Mortality/survival
Primary endpoint: reinterventions within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Trails B/A ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal isometric knee extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional reaching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Madsen symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flowrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: voiding percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for re-irradiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: acute bronchodilatory effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time to recovery within 5% of baseline FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ptosis correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lagophthalmos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attendance rate for breast cancer screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximal LDL-C reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IBS-specific symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-specific quality-of-life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of parents with correct knowledge about hypertension leading to kidney failure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of parents intending to see a health professional about their BP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ability to walk 300 m or more in 6 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Ventilator-associated pneumonia (VAP) rate
Endpoint domain: Adverse events/effects
Primary endpoint: peak uroflow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of high-grade congestive heart failure (CHF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of acute exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in fasting C-peptide concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: SPPB (Short Physical Performance Battery)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 400-m walk failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary epinephrine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mean depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: coping-planning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: serum concentrations of IL-1α/IL-1β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Medication adherence level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Heart functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: postdose SCr increase > or = 0.5 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Knowledge of Pap test purpose
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total influx of inflammatory cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diastolic blood pressure fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in ureteral stent related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sentence recognition in moderate noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioural pain expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge on clopidogrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Catheterization duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change of Li-E line
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 1 Neutropenia rate
Endpoint domain: Adverse events/effects
Primary endpoint: Radiographic tunnel position measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rates of adverse treatment events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean VAS changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desired treatment effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax and AUCt for bisoprolol and amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in lower extremity function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of Robot Gym therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CVD event
Endpoint domain: Mortality/survival
Primary endpoint: HIV‐1 RNA change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4 increases at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Recurrence of venous thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: recurrent P. aeruginosa isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: placebo-subtracted weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mortality within 30 days after surgical revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Limb salvage rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss from baseline to 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident heart failure (HF) cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Modified Yale Preoperative Anxiety Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Osteonecrosis (ON)
Endpoint domain: Mortality/survival
Primary endpoint: Parasitaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: years traded off
Endpoint domain: Mortality/survival
Primary endpoint: ease of administration
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: overall performance
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration and severity of influenza symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity and reliability of the Chinese version of Attitudes towards guidelines scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: contrast volume (ml) used until completion of CAG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluoroscopy time (min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe spasm rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sweet drink consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduced glutathione concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ferric reducing antioxidant potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total score on HAM-D, MADRS and CGI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student-instructor interaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student examination scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Student appreciation of coursework
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of dumping
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of plugging
Endpoint domain: Adverse events/effects
Primary endpoint: total number of lumbar somatic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of asymmetric landmarks on standing structural examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: POGO score estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ST segment resolution > or = 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Length of stay at hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mortality on day 90
Endpoint domain: Mortality/survival
Primary endpoint: Quality of life in daily activities
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in scalp DHT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Variability of ENFs/mm counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of pulpal and soft-tissue anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival impact of SI
Endpoint domain: Mortality/survival
Primary endpoint: Disposal of unused opioid medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total hemorrhage expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in perceived risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decreases in cancer worry
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in HbA1(c) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: dual-task interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair nickel levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair chromium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day reoperation rates
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of infectious morbidities
Endpoint domain: Adverse events/effects
Primary endpoint: Posttransplant hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction of hair loss (modified wash test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair growth stimulation (evaluated by hair density)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair Mass Index increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chance of cure
Endpoint domain: Mortality/survival
Primary endpoint: graft rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of analgesia consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra‐procedure bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: High frequency component of heart rate variability (HF HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RMS error on a tracking task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time on tests of memory and attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive affective response to exercise
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived exertion during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days exercised during follow-up
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: metabolic syndrome incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: PAI‐1 concentration after 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of malignant melanoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: percentage of phenol remaining in the nailfold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arrival at maternity ward in active labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Use of epidural analgesia during labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Suppression of PSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin-6 (IL-6) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cardiac troponin T (cTnT) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in whole mouth plaque scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating TNFalpha levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bond strength on enamel and dentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of skin conductance fluctuations (NSCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sleep latency improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: condom use error rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follicular fluid levels of progesterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Follicular fluid levels of estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Follicular fluid levels of testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Caries increment (Δdmf‐s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Outcome Scale (GOS) at 3 and 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Amount of opioids administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain evaluated with visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N1m/P2m dipole moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: peak flow rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in COWS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of rescue medication administration
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with tracheobronchial colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: clinical and objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: collateral effects of hormonotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: period without disease
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in activity disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target-mediated elimination rate constant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine efficacy against hepatitis E
Endpoint domain: Mortality/survival
Primary endpoint: Maintenance of antibodies against HEV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dental plaque weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower levels of plaque acetic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower counts of salivary and plaque mutans streptococci
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Global Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean treatment satisfaction and recommendation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrence of melasma
Endpoint domain: Adverse events/effects
Primary endpoint: Mean healing time for partial avulsion wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of mutations in YMDD region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in total cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients achieving NCEP goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Contraceptive use at 3-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forgiveness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CIBIC+ score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADAS-Cog score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung ultrasonography score (LUS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Excessive bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dissatisfaction regarding the care received
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: systemic arterial compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: aortic root diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PAED scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Death, recurrent MI and stroke at one year
Endpoint domain: Mortality/survival
Primary endpoint: Rates of complete ST-segment resolution (> or =70%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Likelihood of achieving 100% block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: day 28 mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: development of ARDS
Endpoint domain: Adverse events/effects
Primary endpoint: Hospital duration after surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Use of postoperative opioids analgesics
Endpoint domain: Adverse events/effects
Primary endpoint: modern contraceptive use at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes